|
WO2021066549A1
|
|
Lactobacillus acidophilus kbl409 strain and use thereof
|
|
KR20210014576A
|
|
Kit for predicting or diagnosing nonalcoholic fatty liver disease, and Composition for treating or preventing thereof
|
|
KR20190133639A
|
|
Lactobacillus Crispatus KBL693 and Use Thereof
|
|
WO2019216662A1
|
|
Lactobacillus paracasei strain and use thereof
|
|
KR20190094125A
|
|
Lactobacillus plantarum KBL396 and Use Thereof
|
|
KR20190060271A
|
|
Lactobacillus Fermentum KBL 375 and Use Thereof
|
|
KR20190033897A
|
|
Clostridium scindens having inhibitory effect against Clostridium difficile
|
|
KR20190033902A
|
|
Lactobacillus plantarum having inhibitory effect against Clostridium difficile
|
|
KR101815692B1
|
|
The human oral microbiota in diagnosis of metabolic syndrome
|
|
KR20160123983A
|
|
Lactobacilli having inhibitory effect against pathogenic microorganisms in vagina
|
